About Innorex
Innorex is a Healthcare company based in Mumbai (India) founded in 2009. Pharmaceutical sourcing and supply services are offered by Innorex in India. Its Indian entity Innorex Pharmaceuticals Private Limited reported revenue of ₹22.73 Cr. Innorex offers products and services including APIs and Formulations. Its focus areas include Services, Formulation Development, Analytical and Supply Services and Pharmaceuticals.
Company details
Over the last 15 years, a portfolio of almost 900 products has been developed by Innorex through a strong supplier base with state-of-the-art facilities. Precise documentation is maintained to support product registration and seamless supply chains. A team with over 100 years of cumulative experience is utilized to address global pharmaceutical sourcing needs, including marketing infrastructures and strategic partnerships across geographies, positioning Innorex as a key access point for such requirements.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn X Facebook
- Legal Name Innorex Pharmaceuticals Pvt. Ltd
- Date of Incorporation 05 Aug, 2009
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹22.73 Cr
FY 2025 · +90% YoY
- Net Profit₹5.65 Cr
FY 2025 · 25% margin
- EBITDA₹6.06 Cr
FY 2025 · 27% margin
Associated legal entities of Innorex
Innorex operates through Innorex Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Innorex Pharmaceuticals Private Limited CIN U24239MH2009PTC194675 | Active | 05 Aug 2009 | Mumbai, Maharashtra | ₹22.7 Cr | 2 | View details |
Products & Services of Innorex
Innorex offers a comprehensive portfolio of products and services, including APIs and Formulations.
Active Pharmaceutical Ingredients are supplied by Innorex from manufacturers holding cGMP and ISO certifications for various market needs.
Finished formulations are provided by Innorex, including oncology and general injectables to address customer requirements.
Board of directors of Innorex Pharmaceuticals Private Limited (Innorex)
Innorex Pharmaceuticals Private Limited is the primary company behind Innorex. The board of Innorex Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Shalaka Prashant Rele, appointed in 2009. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shalaka Prashant Rele DIN 02218449 | Director | 05 Aug 2009 | 17 yrs 2 mo | Innorex Pharmaceuticals Private Limited |
| Prashant Raghunandan Rele DIN 00563170 | Director | 20 Aug 2018 | 8 yrs 2 mo | Innorex Pharmaceuticals Private Limited |
Financials of Innorex
Figures of Innorex Pharmaceuticals Private Limited, the primary company behind Innorex, for FY 2025. Revenue was ₹22.73 Cr (+90% year on year). Net profit was ₹5.65 Cr (25% margin). EBITDA was ₹6.06 Cr (27% margin). Revenue has grown at a compounded annual rate of +23% over three years and +10% over five years.
- ₹22.73 CrRevenue · FY 2025 · +90% YoY
- ₹5.65 CrNet profit · 25% margin
- ₹6.06 CrEBITDA · 27% margin
- ₹1 LakhPaid-up capital
- +23%Revenue CAGR, 3 years
- +10%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Innorex Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Innorex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Innorex
Innorex was founded in 2009.
Innorex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Innorex, Innorex Pharmaceuticals Private Limited, reported revenue of ₹22.73 Cr for FY 2025, up 90% year on year.
Over the last 15 years, a portfolio of almost 900 products has been developed by Innorex through a strong supplier base with state-of-the-art facilities. Precise documentation is maintained to support product registration and seamless supply chains. A team with over 100 years of cumulative experience is utilized to address global pharmaceutical sourcing needs, including marketing infrastructures and strategic partnerships across geographies, positioning Innorex as a key access point for such requirements.
Innorex offers APIs and Formulations.
Innorex operates through Innorex Pharmaceuticals Private Limited.
The legal entities of Innorex currently have 2 directors, including Prashant Raghunandan Rele, Shalaka Prashant Rele.